These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34718756)

  • 21. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
    Curr Vasc Pharmacol; 2021; 19(1):77-90. PubMed ID: 32196451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Pol Arch Med Wewn; 2015; 125(9):631-40. PubMed ID: 26176325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K status and mortality after kidney transplantation: a cohort study.
    Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
    Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
    Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
    J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn.
    Neofytou IE; Stamou A; Demopoulos A; Roumeliotis S; Zebekakis P; Liakopoulos V; Stamellou E; Dounousi E
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease.
    Kaesler N; Schreibing F; Speer T; Puente-Secades S; Rapp N; Drechsler C; Kabgani N; Kuppe C; Boor P; Jankowski V; Schurgers L; Kramann R; Floege J
    Kidney Int; 2022 Feb; 101(2):338-348. PubMed ID: 34774554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet?
    Roumeliotis S; Duni A; Vaios V; Kitsos A; Liakopoulos V; Dounousi E
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins, vascular calcification, and vitamin K-dependent proteins: Is there a relation?
    Zhelyazkova-Savova MD; Yotov YT; Nikolova MN; Nazifova-Tasinova NF; Vankova DG; Atanasov AA; Galunska BT
    Kaohsiung J Med Sci; 2021 Jul; 37(7):624-631. PubMed ID: 33634559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship.
    Fusaro M; Crepaldi G; Maggi S; Galli F; D'Angelo A; Calò L; Giannini S; Miozzo D; Gallieni M
    J Endocrinol Invest; 2011 Apr; 34(4):317-23. PubMed ID: 21088475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.
    McCabe KM; Booth SL; Fu X; Shobeiri N; Pang JJ; Adams MA; Holden RM
    Kidney Int; 2013 May; 83(5):835-44. PubMed ID: 23344475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: A double-blind, randomized, placebo-controlled clinical trial.
    Eelderink C; Kremer D; Riphagen IJ; Knobbe TJ; Schurgers LJ; Pasch A; Mulder DJ; Corpeleijn E; Navis G; Bakker SJL; de Borst MH; Te Velde-Keyzer CA
    Am J Transplant; 2023 Apr; 23(4):520-530. PubMed ID: 36695702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health.
    Bellone F; Cinquegrani M; Nicotera R; Carullo N; Casarella A; Presta P; Andreucci M; Squadrito G; Mandraffino G; Prunestì M; Vocca C; De Sarro G; Bolignano D; Coppolino G
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial.
    Holden RM; Booth SL; Zimmerman D; Moist L; Norman PA; Day AG; Menard A; Fu X; Shea MK; Babiolakis CS; Nolan R; Turner ME; Ward E; Kaufmann M; Adams MA; Heyland DK
    Nephrol Dial Transplant; 2023 Feb; 38(3):746-756. PubMed ID: 35641194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland.
    Wyskida K; Żak-Gołąb A; Wajda J; Klein D; Witkowicz J; Ficek R; Rotkegel S; Spiechowicz U; Kocemba Dyczek J; Ciepał J; Olszanecka-Glinianowicz M; Więcek A; Chudek J
    Int Urol Nephrol; 2016 May; 48(5):765-71. PubMed ID: 27000106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
    Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin K and cardiovascular complications in chronic kidney disease patients.
    Kaesler N; Schurgers LJ; Floege J
    Kidney Int; 2021 Nov; 100(5):1023-1036. PubMed ID: 34310988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.
    Caluwé R; Vandecasteele S; Van Vlem B; Vermeer C; De Vriese AS
    Nephrol Dial Transplant; 2014 Jul; 29(7):1385-90. PubMed ID: 24285428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
    Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
    J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.